La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Banca Mediolanum Croissance future

Future contrôle des critères 2/6

Les bénéfices de Banca Mediolanum devraient diminuer de 1.1% par an tandis que son chiffre d'affaires annuel devrait croître de 14.1% par an. Le BPA devrait croître de diminuer de 1.3% par an. Le rendement des capitaux propres devrait être 20.8% dans 3 ans.

Informations clés

-0.9%

Taux de croissance des bénéfices

-1.1%

Taux de croissance du BPA

Diversified Financial croissance des bénéfices	34.7%
Taux de croissance des recettes	13.2%
Rendement futur des capitaux propres	21.1%
Couverture par les analystes	Good
Dernière mise à jour	02 Sep 2024

Mises à jour récentes de la croissance future

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Aug 04

Recent updates

If EPS Growth Is Important To You, Banca Mediolanum (BIT:BMED) Presents An Opportunity

Sep 09

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Aug 04

I Ran A Stock Scan For Earnings Growth And Banca Mediolanum (BIT:BMED) Passed With Ease

Apr 08

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Dec 21

New Forecasts: Here's What Analysts Think The Future Holds For Banca Mediolanum S.p.A. (BIT:BMED)

Feb 15

How Many Banca Mediolanum S.p.A. (BIT:BMED) Shares Did Insiders Buy, In The Last Year?

Jan 31

If You Had Bought Banca Mediolanum's (BIT:BMED) Shares A Year Ago You Would Be Down 21%

Dec 28

Here's Why I Think Banca Mediolanum (BIT:BMED) Is An Interesting Stock

Nov 23

Prévisions de croissance des bénéfices et des revenus

BIT:BMED - Estimations futures des analystes et données financières antérieures (EUR Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	3,145	891	835	N/A	2
12/31/2025	3,057	898	848	N/A	3
12/31/2024	2,980	910	872	N/A	3
6/30/2024	2,066	908	581	631	N/A
3/31/2024	1,984	864	N/A	N/A	N/A
12/31/2023	1,870	822	-1,806	-1,754	N/A
9/30/2023	1,712	702	N/A	N/A	N/A
6/30/2023	1,587	629	132	200	N/A
3/31/2023	1,468	571	N/A	N/A	N/A
12/31/2022	1,377	507	2,239	2,298	N/A
9/30/2022	1,585	714	N/A	N/A	N/A
6/30/2022	1,547	685	1,034	1,093	N/A
3/31/2022	1,585	694	N/A	N/A	N/A
12/31/2021	1,599	713	848	909	N/A
9/30/2021	1,425	560	N/A	N/A	N/A
6/30/2021	1,408	553	81	119	N/A
3/31/2021	1,310	496	N/A	N/A	N/A
12/31/2020	1,215	434	-18	24	N/A
9/30/2020	1,457	531	N/A	N/A	N/A
6/30/2020	1,445	545	162	192	N/A
3/31/2020	1,470	566	N/A	N/A	N/A
12/31/2019	1,469	565	328	363	N/A
9/30/2019	1,038	268	N/A	N/A	N/A
6/30/2019	1,012	252	257	305	N/A
3/31/2019	1,005	268	N/A	N/A	N/A
12/31/2018	987	256	312	357	N/A
9/30/2018	1,031	373	181	248	N/A
6/30/2018	1,006	359	207	278	N/A
3/31/2018	944	355	N/A	N/A	N/A
12/31/2017	970	380	N/A	275	N/A
9/30/2017	938	368	N/A	N/A	N/A
6/30/2017	983	420	N/A	-789	N/A
3/31/2017	1,007	405	N/A	N/A	N/A
12/31/2016	985	394	N/A	-849	N/A
9/30/2016	1,068	432	N/A	N/A	N/A
6/30/2016	1,014	382	N/A	155	N/A
3/31/2016	1,009	374	N/A	N/A	N/A
12/31/2015	1,103	439	N/A	-7,651	N/A
12/31/2013	868	188	N/A	-454	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Les bénéfices de BMED devraient diminuer au cours des 3 prochaines années ( -1.1% par an).

Bénéfices vs marché: Les bénéfices de BMED devraient diminuer au cours des 3 prochaines années ( -1.1% par an).

Croissance élevée des bénéfices: Les bénéfices de BMED devraient baisser au cours des trois prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de BMED ( 14.1% par an) devrait croître plus rapidement que le marché Italian ( 3.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de BMED ( 14.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de BMED devrait être élevé dans 3 ans ( 20.8 %)

Banca Mediolanum Croissance future

Future contrôle des critères 2/6

Informations clés

Mises à jour récentes de la croissance future

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Price target increased by 7.6% to €10.68

Analysts update estimates

Recent updates

If EPS Growth Is Important To You, Banca Mediolanum (BIT:BMED) Presents An Opportunity

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Second quarter 2024 earnings released: EPS: €0.31 (vs €0.25 in 2Q 2023)

Banca Mediolanum S.p.A. (BIT:BMED) commences an Equity Buyback for 8,000,000 shares, representing 1.08% for €66 million, under the authorization approved on April 18, 2024.

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues exceed analyst expectations

Is Now The Time To Put Banca Mediolanum (BIT:BMED) On Your Watchlist?

Upcoming dividend of €0.42 per share

Banca Mediolanum (BIT:BMED) Will Pay A Larger Dividend Than Last Year At €0.42

Final dividend of €0.42 announced

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: €0.28 (vs €0.18 in 3Q 2022)

Now 21% undervalued

Second quarter 2023 earnings released: EPS: €0.25 (vs €0.17 in 2Q 2022)

Now 20% undervalued after recent price drop

Upcoming dividend of €0.26 per share at 6.0% yield

Now 21% undervalued

Price target increased by 7.6% to €10.68

Full year 2022 earnings released: EPS: €0.71 (vs €0.97 in FY 2021)

Should You Be Adding Banca Mediolanum (BIT:BMED) To Your Watchlist Today?

Banca Mediolanum S.p.A. to Report Q1, 2023 Results on May 10, 2023

Upcoming dividend of €0.24 per share

Third quarter 2022 earnings released

Banca Mediolanum (BIT:BMED) Has Affirmed Its Dividend Of €0.24

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Banca Mediolanum S.p.A. to Report Q3, 2022 Results on Nov 09, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of €0.35 per share

I Ran A Stock Scan For Earnings Growth And Banca Mediolanum (BIT:BMED) Passed With Ease

CEO & Director recently bought €167k worth of stock

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Banca Mediolanum S.P.A. Proposes Balanced Dividend Distribution for the Year 2021

Banca Mediolanum S.p.A. to Report Fiscal Year 2021 Results on Feb 10, 2022

Now 22% undervalued after recent price drop

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Third quarter 2021 earnings released

Upcoming dividend of €0.75 per share

Second quarter 2021 earnings released: EPS €0.18 (vs €0.11 in 2Q 2020)

Upcoming dividend of €0.027 per share

New 90-day high: €7.75

New Forecasts: Here's What Analysts Think The Future Holds For Banca Mediolanum S.p.A. (BIT:BMED)

Full year 2020 earnings released

Banca Mediolanum S.p.A. to Report Q3, 2021 Results on Nov 10, 2021

Investor sentiment improved over the past week

How Many Banca Mediolanum S.p.A. (BIT:BMED) Shares Did Insiders Buy, In The Last Year?

Analysts update estimates

If You Had Bought Banca Mediolanum's (BIT:BMED) Shares A Year Ago You Would Be Down 21%

Here's Why I Think Banca Mediolanum (BIT:BMED) Is An Interesting Stock

Third quarter 2020 earnings released: EPS €0.14

New 90-day low: €6.05

New 90-day low: €6.15

First half earnings released

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance